Results 211 to 220 of about 672,477 (393)
Fibroblast growth factor receptor 2 (FGFR2) is required for meibomian gland homeostasis in the adult mouse [PDF]
Huang, Andrew J. W.+3 more
core +2 more sources
Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy. [PDF]
Tsimafeyeu I.
europepmc +1 more source
Requirement for Anticoagulant Heparan Sulfate in the Fibroblast Growth Factor Receptor Complex [PDF]
Wallace L. McKeehan+2 more
openalex +1 more source
Post‐surgical tumor therapy struggles with recurrence and inefficient healing. Anti‐tumor DNA aptamer functionalized gelatin hydrogels, Apt‐GelMA, simultaneously address both issues by suppressing tumor regrowth via targeted tumor cell inhibition and enhancing wound healing through improved cell adhesion and migration. Their biocompatibility, stability,
Tianyue Li+11 more
wiley +1 more source
Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors. [PDF]
Li I+5 more
europepmc +1 more source
Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. [PDF]
Brendan D. Galvin+4 more
openalex +1 more source
Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth+2 more
wiley +1 more source